The diagnostic usefulness of capture assays for measuring global/specific extracellular micro-particles in plasma

被引:24
作者
Amiral, Jean [1 ]
Seghatchian, Jerard [2 ]
机构
[1] HYPHEN BioMed Res, F-95000 Neuville Sur Oise, France
[2] Int Consultant Blood Components Qual Safety Impro, London, England
关键词
TISSUE FACTOR ACTIVITY; FACTOR-POSITIVE MICROPARTICLES; CELL-DERIVED MICROPARTICLES; CIRCULATING PROCOAGULANT MICROPARTICLES; FACTOR-BEARING MICROPARTICLES; FLOW-CYTOMETRIC ASSAY; PLATELET MICROPARTICLES; ENDOTHELIAL-CELLS; MYOCARDIAL-INFARCTION; VENOUS THROMBOSIS;
D O I
10.1016/j.transci.2015.10.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Capture assays were developed and validated for measuring the global pro-coagulant activity of micro-particles (MPs, mainly originated from platelets), or specific extravascular cellular MPs (released from erythrocytes, leukocytes, monocytes, endothelial cells) as those exposing TF (MP-TF, mainly observed in patients with some cancers). Conversely to Flow Cytometry methods, these capture assays measure all coagulant activity associated with MPs, through thrombin generation (MP-Activity) or Factor Xa generation (MP-TF), and therefore they bring a complementary information, as they are more specific for the pro-coagulant activity associated with MPs. Small particles (<0.40 mu) exposing Phosphatidyl Serine (PS) exhibit a greater pro-coagulant surface than larger MPs (0.40 to >1.00 mu), those preferentially measured with flow cytometry. Activity associated with MPs is a consequence of disease but can also be a cause contributing to pathological processes and development of thrombo-embolic events. In many diseases, flow cytometry and capture assays do not totally correlate, and have different associations with disease evolution. Optimized capture based assays are presented and discussed, along with their performance characteristics and some applications. They can be performed in any technically skillful hemostasis laboratory, using a thermostated ELISA equipment, or an incubator. Dynamic ranges for MP-Activity assay is from <0.1 nM to >2.5 nM Phospholipids, expressed as Phosphatidyl Serine (PS) equivalent, in the tested dilution. For MP-TF the very sensitive bio-immunoassay reported allows measuring concentrations from <0.10 pg/ml (TF equivalent) to >5.00 pg/ml, in the assayed dilution. No measurable MP-TF was found in normals, although an important concentration was generated from whole blood treated with Lipo-Poly-Saccharides. Capture based assays are then highly useful in the laboratory setting for measuring the activities associated with pro-coagulant, or specific cellular MPs. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 76 条
[1]   Enclothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome [J].
Agouni, Abdelali ;
Lagrue-Lak-Hal, Anne Helene ;
Ducluzeau, Pierre Henri ;
Mostefai, Hadj Ahmed ;
Draunet-Busson, Catherine ;
Leftheriotis, Georges ;
Heymes, Christophe ;
Martinez, Maria Carmen ;
Andriantsitohaina, Ramaroson .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (04) :1210-1219
[2]   Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability [J].
Aleman, M. M. ;
Gardiner, C. ;
Harrison, P. ;
Wolberg, A. S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) :2251-2261
[3]   Leukocyte-Derived Microparticles in Vascular Homeostasis [J].
Angelillo-Scherrer, Anne .
CIRCULATION RESEARCH, 2012, 110 (02) :356-369
[4]   The role of microparticles in inflammation and thrombosis [J].
Ardoin, S. P. ;
Shanahan, J. C. ;
Pisetsky, D. S. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 66 (2-3) :159-165
[5]   The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection [J].
Aupeix, K ;
Hugel, B ;
Martin, T ;
Bischoff, P ;
Lill, H ;
Pasquali, JL ;
Freyssinet, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1546-1554
[6]   Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma [J].
Auwerda, Johannes J. A. ;
Yuana, Yuana ;
Osanto, Susanne ;
de Maat, Moniek P. M. ;
Sonneveld, Pieter ;
Bertina, Rogier M. ;
Leebeek, Frank W. G. .
THROMBOSIS AND HAEMOSTASIS, 2011, 105 (01) :14-20
[7]   Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay [J].
Ayers, Lisa ;
Kohler, Malcolm ;
Harrison, Paul ;
Sargent, Ian ;
Dragovic, Rebecca ;
Schaap, Marianne ;
Nieuwland, Rienk ;
Brooks, Susan A. ;
Ferry, Berne .
THROMBOSIS RESEARCH, 2011, 127 (04) :370-377
[8]   Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? [J].
Baron, Morgane ;
Boulanger, Chantal M. ;
Staels, Bart ;
Tailleux, Anne .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (07) :1365-1376
[9]   Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers [J].
Bharthuar, Anubha ;
Khorana, Alok A. ;
Hutson, Alan ;
Wang, Jian-Guo ;
Key, Nigel S. ;
Mackman, Nigel ;
Iyer, Renuka V. .
THROMBOSIS RESEARCH, 2013, 132 (02) :180-184
[10]   Protective and pathological roles of tissue factor in the heart [J].
Bode, M. F. ;
Mackman, N. .
HAMOSTASEOLOGIE, 2015, 35 (01) :37-46